Niche regulatory focus Target pharmaceutical manufacturers and biotech firms seeking GMP audits, regulatory affairs guidance, and quality systems optimization, especially those pursuing or expanding botanical drug programs with FDA milestones.

Boutique global play Leverage the firm’s small size and international scope to position as a nimble partner for global GMP and quality assurance projects, offering personalized consulting for multijurisdictional regulatory requirements.

FDA botanical momentum Capitalize on experience with the first two FDA-approved botanical drugs to connect with firms developing botanical or natural product therapeutics, highlighting track record in regulatory submissions and approvals.

Revenue growth upside Explore mid-market pharmaceutical and biotech opportunities to scale services from a $1M–$10M revenue base into broader engagements such as full QA/QC audits, regulatory affairs outsourcing, and manufacturing compliance programs.

Strategic partnerships Position as a complementary partner to larger CROs and pharma services networks by offering specialized expertise in GMP audits and regulatory submissions, enabling referrals and joint bid opportunities.